Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.908 USD | +2.01% | +3.02% | -37.32% |
May. 02 | Zepp Health Corporation Announces Availability of the Amazfit Bip 5 Unity | CI |
Apr. 30 | Zepp Healths to Launch Amazfit Helio Ring for US Market May 15 | MT |
Summary
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Phones & Handheld Devices
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-37.32% | 53.39M | - | D+ | |
+18.84% | 1.89B | D+ | ||
-15.79% | 1.12B | B- | ||
+12.33% | 842M | B- | ||
+53.66% | 779M | - | ||
-11.83% | 773M | B- | ||
+54.99% | 732M | - | ||
-28.07% | 368M | - | - | |
-9.33% | 290M | - | D+ | |
+26.57% | 106M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ZEPP Stock
- Ratings Zepp Health Corporation